Diagnostic cut‐off of Aspergillus fumigatus‐specific IgG in the diagnosis of chronic pulmonary aspergillosis
Aspergillus fumigatus‐specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis (CPA). However, the cut‐off value for A. fumigatus‐specific IgG remains unknown. We included consecutive treatment‐naïve subjects with chronic cavitary pulmonary aspergillosis (CCPA, cases). The...
Saved in:
Published in | Mycoses Vol. 61; no. 10; pp. 770 - 776 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
Wiley Subscription Services, Inc
01.10.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Aspergillus fumigatus‐specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis (CPA). However, the cut‐off value for A. fumigatus‐specific IgG remains unknown. We included consecutive treatment‐naïve subjects with chronic cavitary pulmonary aspergillosis (CCPA, cases). The controls were subjects with treated pulmonary tuberculosis, who had residual radiological abnormality and minimal symptoms. The diagnosis of CCPA was based on consistent clinicoradiological features along with demonstration of Aspergillus infection (growth of Aspergillus in sputum or bronchoalveolar lavage fluid [BALF] culture; serum or BALF galactomannan index >0.5 and >1, respectively). For determining the cut‐off of A. fumigatus‐specific IgG (Phadia), subjects were randomly classified as derivation (two‐thirds) and validation (one‐third) cohort. One hundred and thirty‐seven cases and 50 controls were included. The best cut‐off value for A. fumigatus‐specific IgG (derivation cohort) was 27.3 mgA/L (AUROC, 0.976) at a sensitivity and specificity of 95.6% and 100%, respectively. Using a cut‐off of 27 mgA/L, the sensitivity and specificity in the validation cohort was 91.3% and 100%, respectively. In contrast, the sensitivity of Aspergillus precipitins was only 25.5%. At a cut‐off value of 27 mgA/L, A. fumigatus‐specific IgG is a reliable test with high sensitivity and specificity in the diagnosis of CPA. More studies are required to confirm our findings. |
---|---|
AbstractList | Aspergillus fumigatus-specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis (CPA). However, the cut-off value for A. fumigatus-specific IgG remains unknown. We included consecutive treatment-naïve subjects with chronic cavitary pulmonary aspergillosis (CCPA, cases). The controls were subjects with treated pulmonary tuberculosis, who had residual radiological abnormality and minimal symptoms. The diagnosis of CCPA was based on consistent clinicoradiological features along with demonstration of Aspergillus infection (growth of Aspergillus in sputum or bronchoalveolar lavage fluid [BALF] culture; serum or BALF galactomannan index >0.5 and >1, respectively). For determining the cut-off of A. fumigatus-specific IgG (Phadia), subjects were randomly classified as derivation (two-thirds) and validation (one-third) cohort. One hundred and thirty-seven cases and 50 controls were included. The best cut-off value for A. fumigatus-specific IgG (derivation cohort) was 27.3 mgA/L (AUROC, 0.976) at a sensitivity and specificity of 95.6% and 100%, respectively. Using a cut-off of 27 mgA/L, the sensitivity and specificity in the validation cohort was 91.3% and 100%, respectively. In contrast, the sensitivity of Aspergillus precipitins was only 25.5%. At a cut-off value of 27 mgA/L, A. fumigatus-specific IgG is a reliable test with high sensitivity and specificity in the diagnosis of CPA. More studies are required to confirm our findings. Aspergillus fumigatus-specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis (CPA). However, the cut-off value for A. fumigatus-specific IgG remains unknown. We included consecutive treatment-naïve subjects with chronic cavitary pulmonary aspergillosis (CCPA, cases). The controls were subjects with treated pulmonary tuberculosis, who had residual radiological abnormality and minimal symptoms. The diagnosis of CCPA was based on consistent clinicoradiological features along with demonstration of Aspergillus infection (growth of Aspergillus in sputum or bronchoalveolar lavage fluid [BALF] culture; serum or BALF galactomannan index >0.5 and >1, respectively). For determining the cut-off of A. fumigatus-specific IgG (Phadia), subjects were randomly classified as derivation (two-thirds) and validation (one-third) cohort. One hundred and thirty-seven cases and 50 controls were included. The best cut-off value for A. fumigatus-specific IgG (derivation cohort) was 27.3 mgA/L (AUROC, 0.976) at a sensitivity and specificity of 95.6% and 100%, respectively. Using a cut-off of 27 mgA/L, the sensitivity and specificity in the validation cohort was 91.3% and 100%, respectively. In contrast, the sensitivity of Aspergillus precipitins was only 25.5%. At a cut-off value of 27 mgA/L, A. fumigatus-specific IgG is a reliable test with high sensitivity and specificity in the diagnosis of CPA. More studies are required to confirm our findings.Aspergillus fumigatus-specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis (CPA). However, the cut-off value for A. fumigatus-specific IgG remains unknown. We included consecutive treatment-naïve subjects with chronic cavitary pulmonary aspergillosis (CCPA, cases). The controls were subjects with treated pulmonary tuberculosis, who had residual radiological abnormality and minimal symptoms. The diagnosis of CCPA was based on consistent clinicoradiological features along with demonstration of Aspergillus infection (growth of Aspergillus in sputum or bronchoalveolar lavage fluid [BALF] culture; serum or BALF galactomannan index >0.5 and >1, respectively). For determining the cut-off of A. fumigatus-specific IgG (Phadia), subjects were randomly classified as derivation (two-thirds) and validation (one-third) cohort. One hundred and thirty-seven cases and 50 controls were included. The best cut-off value for A. fumigatus-specific IgG (derivation cohort) was 27.3 mgA/L (AUROC, 0.976) at a sensitivity and specificity of 95.6% and 100%, respectively. Using a cut-off of 27 mgA/L, the sensitivity and specificity in the validation cohort was 91.3% and 100%, respectively. In contrast, the sensitivity of Aspergillus precipitins was only 25.5%. At a cut-off value of 27 mgA/L, A. fumigatus-specific IgG is a reliable test with high sensitivity and specificity in the diagnosis of CPA. More studies are required to confirm our findings. Aspergillus fumigatus‐specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis (CPA). However, the cut‐off value for A. fumigatus‐specific IgG remains unknown. We included consecutive treatment‐naïve subjects with chronic cavitary pulmonary aspergillosis (CCPA, cases). The controls were subjects with treated pulmonary tuberculosis, who had residual radiological abnormality and minimal symptoms. The diagnosis of CCPA was based on consistent clinicoradiological features along with demonstration of Aspergillus infection (growth of Aspergillus in sputum or bronchoalveolar lavage fluid [BALF] culture; serum or BALF galactomannan index >0.5 and >1, respectively). For determining the cut‐off of A. fumigatus‐specific IgG (Phadia), subjects were randomly classified as derivation (two‐thirds) and validation (one‐third) cohort. One hundred and thirty‐seven cases and 50 controls were included. The best cut‐off value for A. fumigatus‐specific IgG (derivation cohort) was 27.3 mgA/L (AUROC, 0.976) at a sensitivity and specificity of 95.6% and 100%, respectively. Using a cut‐off of 27 mgA/L, the sensitivity and specificity in the validation cohort was 91.3% and 100%, respectively. In contrast, the sensitivity of Aspergillus precipitins was only 25.5%. At a cut‐off value of 27 mgA/L, A. fumigatus‐specific IgG is a reliable test with high sensitivity and specificity in the diagnosis of CPA. More studies are required to confirm our findings. Aspergillus fumigatus ‐specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis ( CPA ). However, the cut‐off value for A. fumigatus ‐specific IgG remains unknown. We included consecutive treatment‐naïve subjects with chronic cavitary pulmonary aspergillosis ( CCPA , cases). The controls were subjects with treated pulmonary tuberculosis, who had residual radiological abnormality and minimal symptoms. The diagnosis of CCPA was based on consistent clinicoradiological features along with demonstration of Aspergillus infection (growth of Aspergillus in sputum or bronchoalveolar lavage fluid [ BALF ] culture; serum or BALF galactomannan index >0.5 and >1, respectively). For determining the cut‐off of A. fumigatus ‐specific IgG (Phadia), subjects were randomly classified as derivation (two‐thirds) and validation (one‐third) cohort. One hundred and thirty‐seven cases and 50 controls were included. The best cut‐off value for A. fumigatus ‐specific IgG (derivation cohort) was 27.3 mgA/L ( AUROC , 0.976) at a sensitivity and specificity of 95.6% and 100%, respectively. Using a cut‐off of 27 mgA/L, the sensitivity and specificity in the validation cohort was 91.3% and 100%, respectively. In contrast, the sensitivity of Aspergillus precipitins was only 25.5%. At a cut‐off value of 27 mgA/L, A. fumigatus ‐specific IgG is a reliable test with high sensitivity and specificity in the diagnosis of CPA . More studies are required to confirm our findings. |
Author | Dhooria, Sahajal Aggarwal, Ashutosh Nath Chakrabarti, Arunaloke Choudhary, Hansraj Garg, Mandeep Agarwal, Ritesh Sehgal, Inderpaul Singh |
Author_xml | – sequence: 1 givenname: Inderpaul Singh orcidid: 0000-0002-6505-6019 surname: Sehgal fullname: Sehgal, Inderpaul Singh organization: Postgraduate Institute of Medical Education and Research (PGIMER) – sequence: 2 givenname: Hansraj surname: Choudhary fullname: Choudhary, Hansraj organization: Postgraduate Institute of Medical Education and Research (PGIMER) – sequence: 3 givenname: Sahajal surname: Dhooria fullname: Dhooria, Sahajal organization: Postgraduate Institute of Medical Education and Research (PGIMER) – sequence: 4 givenname: Ashutosh Nath surname: Aggarwal fullname: Aggarwal, Ashutosh Nath organization: Postgraduate Institute of Medical Education and Research (PGIMER) – sequence: 5 givenname: Mandeep surname: Garg fullname: Garg, Mandeep organization: Postgraduate Institute of Medical Education and Research (PGIMER) – sequence: 6 givenname: Arunaloke surname: Chakrabarti fullname: Chakrabarti, Arunaloke organization: Postgraduate Institute of Medical Education and Research (PGIMER) – sequence: 7 givenname: Ritesh orcidid: 0000-0003-2547-7668 surname: Agarwal fullname: Agarwal, Ritesh email: agarwal.ritesh@outlook.in organization: Postgraduate Institute of Medical Education and Research (PGIMER) |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29920796$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1OGzEUha0KVELaRV-gGqmbshjwT2zHS5RCiARiQxddWY7HThzN2FN7LJQdj8Az8iQ4BFggtd5Y8v3O0fU5x-DAB28A-IbgKSrnrNvqU4SniH4CIzQhooYU8gMwgoKQmk8gPwLHKW0gRFxg9hkcYSEw5IKNQP_LqZUPaXC60nl4engM1lbBVuepN3Hl2janyubOrdSQUxmXZ-1soRereeV8NaxN1ew9XNoJ9ToGX-Z9brvgVdxW6s1qh3wBh1a1yXx9vcfg9-XF3eyqvr6dL2bn17UmlNBaKYYgJUveIAYbWNY1y4YxoqklmE2V4EskMILcWmEwoVPImSDICMMaKpghY_Bz79vH8DebNMjOJW3aVnkTcpIYUj6ZYF4iGoMfH9BNyNGX7SQu8UJGSFllDL6_UnnZmUb20XXld_ItywKc7AEdQ0rR2HcEQbnrSZae5EtPhT37wGo3qMEFP0Tl2v8p7l1rtv-2ljd_ZnvFM5iApUA |
CitedBy_id | crossref_primary_10_1128_JCM_02018_21 crossref_primary_10_3390_jof6020075 crossref_primary_10_1097_MCP_0000000000001026 crossref_primary_10_1007_s11046_023_00756_8 crossref_primary_10_1007_s11046_023_00751_z crossref_primary_10_1371_journal_pone_0222738 crossref_primary_10_1371_journal_ppat_1008742 crossref_primary_10_1111_myc_13747 crossref_primary_10_1111_myc_13229 crossref_primary_10_1111_myc_13746 crossref_primary_10_3390_jof6040202 crossref_primary_10_3390_jof6040249 crossref_primary_10_1016_S1473_3099_22_00057_3 crossref_primary_10_1021_jacsau_1c00318 crossref_primary_10_1016_j_mycmed_2019_100898 crossref_primary_10_1111_myc_12987 crossref_primary_10_1016_j_ijregi_2022_11_005 crossref_primary_10_1111_myc_13711 crossref_primary_10_2147_IDR_S479714 crossref_primary_10_1016_j_rmed_2020_106290 crossref_primary_10_1016_j_cmi_2019_12_009 crossref_primary_10_1111_myc_13553 crossref_primary_10_1016_j_mycmed_2020_100932 crossref_primary_10_1128_JCM_00538_19 crossref_primary_10_1080_17476348_2020_1750956 crossref_primary_10_3389_fmicb_2022_1060727 crossref_primary_10_1128_JCM_01821_18 crossref_primary_10_1177_20499361211050158 crossref_primary_10_4103_ijrc_ijrc_98_20 crossref_primary_10_1055_s_0043_1776913 crossref_primary_10_1016_j_cmi_2019_01_007 crossref_primary_10_3390_jof7060480 crossref_primary_10_1016_j_jaip_2018_08_034 crossref_primary_10_1093_mmy_myac063 crossref_primary_10_1111_myc_13253 crossref_primary_10_4269_ajtmh_22_0366 crossref_primary_10_1016_j_cmi_2022_11_031 crossref_primary_10_1016_j_mimet_2020_106021 crossref_primary_10_3390_jof8020110 crossref_primary_10_1186_s12890_020_1125_y crossref_primary_10_3390_jof8040400 crossref_primary_10_1016_j_ijmmb_2022_03_002 crossref_primary_10_1097_MCP_0000000000000940 crossref_primary_10_1093_infdis_jiae409 crossref_primary_10_20862_0042_4676_2021_102_5_317_328 crossref_primary_10_1097_MOP_0000000000000898 crossref_primary_10_1007_s11046_024_00917_3 crossref_primary_10_1111_myc_13730 crossref_primary_10_1111_myc_13143 crossref_primary_10_1111_myc_13583 crossref_primary_10_3389_fcimb_2020_602836 crossref_primary_10_1016_j_heliyon_2023_e15356 crossref_primary_10_1177_20499361241253751 crossref_primary_10_7759_cureus_16418 |
Cites_doi | 10.1093/cid/ciw444 10.1111/myc.12541 10.1371/journal.pone.0114745 10.1111/j.1749-6632.1974.tb28200.x 10.1016/j.diagmicrobio.2018.01.001 10.1016/j.cmi.2018.01.002 10.1086/376526 10.1016/j.jinf.2014.01.005 10.1016/j.alit.2018.04.009 10.2471/BLT.11.089441 10.1016/j.jinf.2015.11.003 10.1111/myc.12075 10.1093/mmy/myy012 10.1373/clinchem.2006.067546 10.1093/cid/ciw326 10.3109/13693786.2012.682228 10.1111/1469-0691.12133 10.1111/j.1440-1843.2009.01548.x 10.1183/13993003.00583-2015 10.7150/ijbs.5459 10.1093/mmy/myy024 |
ContentType | Journal Article |
Copyright | 2018 Blackwell Verlag GmbH 2018 Blackwell Verlag GmbH. |
Copyright_xml | – notice: 2018 Blackwell Verlag GmbH – notice: 2018 Blackwell Verlag GmbH. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM M7N 7X8 |
DOI | 10.1111/myc.12815 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Algology Mycology and Protozoology Abstracts (Microbiology C) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Algology Mycology and Protozoology Abstracts (Microbiology C) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Algology Mycology and Protozoology Abstracts (Microbiology C) CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1439-0507 |
EndPage | 776 |
ExternalDocumentID | 29920796 10_1111_myc_12815 MYC12815 |
Genre | article Evaluation Studies Journal Article |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 123 1OB 1OC 29M 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHEFC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 CYRXZ D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBC EBD EBS EJD EMB EMK EMOBN EST ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK0 MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 ZXP ZZTAW ~IA ~KM ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM AAMMB AEFGJ AGXDD AIDQK AIDYY M7N 7X8 |
ID | FETCH-LOGICAL-c3535-aa61053b7d160d0920ebd663c5f3268a97b192107ff9e2358076931e9e6d596e3 |
IEDL.DBID | DR2 |
ISSN | 0933-7407 1439-0507 |
IngestDate | Fri Jul 11 04:31:10 EDT 2025 Fri Jul 25 07:07:34 EDT 2025 Thu Apr 03 07:08:24 EDT 2025 Tue Jul 01 04:30:59 EDT 2025 Thu Apr 24 22:53:09 EDT 2025 Wed Jan 22 16:20:48 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | IgG chronic pulmonary aspergillosis ImmunoCap aspergillosis ELISA |
Language | English |
License | 2018 Blackwell Verlag GmbH. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3535-aa61053b7d160d0920ebd663c5f3268a97b192107ff9e2358076931e9e6d596e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 |
ORCID | 0000-0002-6505-6019 0000-0003-2547-7668 |
PMID | 29920796 |
PQID | 2111063305 |
PQPubID | 2045122 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_2057442793 proquest_journals_2111063305 pubmed_primary_29920796 crossref_primary_10_1111_myc_12815 crossref_citationtrail_10_1111_myc_12815 wiley_primary_10_1111_myc_12815_MYC12815 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | October 2018 2018-10-00 2018-Oct 20181001 |
PublicationDateYYYYMMDD | 2018-10-01 |
PublicationDate_xml | – month: 10 year: 2018 text: October 2018 |
PublicationDecade | 2010 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany – name: Berlin |
PublicationTitle | Mycoses |
PublicationTitleAlternate | Mycoses |
PublicationYear | 2018 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2013; 19 2012; 50 2009; 14 2006; 52 2017; 60 2013; 56 2018; 91 2016; 63 2003; 37 2018 2014; 68 2016; 72 2011; 89 2014; 9 1974; 221 2016; 47 2012; 8 2018; 24 e_1_2_5_15_1 e_1_2_5_14_1 e_1_2_5_17_1 e_1_2_5_9_1 e_1_2_5_16_1 e_1_2_5_8_1 e_1_2_5_11_1 e_1_2_5_7_1 e_1_2_5_10_1 e_1_2_5_6_1 e_1_2_5_13_1 e_1_2_5_21_1 e_1_2_5_5_1 e_1_2_5_12_1 e_1_2_5_22_1 e_1_2_5_4_1 e_1_2_5_3_1 e_1_2_5_2_1 e_1_2_5_19_1 e_1_2_5_18_1 e_1_2_5_20_1 |
References_xml | – volume: 24 start-page: e1 year: 2018 end-page: e38 article-title: Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID‐ECMM‐ERS guideline publication-title: Clin Microbiol Infect – volume: 47 start-page: 45 year: 2016 end-page: 68 article-title: Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management publication-title: Eur Respir J – volume: 63 start-page: e1 year: 2016 end-page: e60 article-title: Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America publication-title: Clin Infect Dis – volume: 37 start-page: S265 issue: Suppl 3 year: 2003 end-page: S280 article-title: Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review publication-title: Clin Infect Dis – volume: 50 start-page: 811 year: 2012 end-page: 817 article-title: Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis publication-title: Med Mycol – volume: 72 start-page: 240 year: 2016 end-page: 249 article-title: Comparison of six Aspergillus‐specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA) publication-title: J Infect – year: 2018 article-title: Concordance between Aspergillus‐specific precipitating antibody and IgG in allergic bronchopulmonary aspergillosis publication-title: Allergol Int – year: 2018 article-title: Prevalence of sensitization to in patients with allergic bronchopulmonary aspergillosis publication-title: Med Mycol – volume: 19 start-page: E197 year: 2013 end-page: E204 article-title: Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis publication-title: Clin Microbiol Infect – volume: 14 start-page: 701 year: 2009 end-page: 708 article-title: Comparison of Aspergillus galactomannan antigen testing with a new cut‐off index and Aspergillus precipitating antibody testing for the diagnosis of chronic pulmonary aspergillosis publication-title: Respirology – volume: 91 start-page: 47 issue: 1 year: 2018 end-page: 51 article-title: Receiver operating characteristic curve analysis of four Aspergillus‐specific IgG assays for the diagnosis of chronic pulmonary aspergillosis publication-title: Diagn Microbiol Infect Dis – volume: 52 start-page: 1785 year: 2006 end-page: 1793 article-title: Quantification of IgG antibodies to and pigeon antigens by ImmunoCAP technology: an alternative to the precipitation technique? publication-title: Clin Chem – volume: 221 start-page: 64 year: 1974 end-page: 75 article-title: Measurement of humoral antibodies to aspergilli publication-title: Ann N Y Acad Sci – volume: 8 start-page: 1418 year: 2012 end-page: 1419 article-title: Consideration in selection of the control group in diagnostic tests publication-title: Int J Biol Sci – volume: 60 start-page: 33 year: 2017 end-page: 39 article-title: Role of ‐specific IgG in diagnosis and monitoring treatment response in allergic bronchopulmonary aspergillosis publication-title: Mycoses – volume: 68 start-page: 494 year: 2014 end-page: 499 article-title: Serum galactomannan antigen test for the diagnosis of chronic pulmonary aspergillosis publication-title: J Infect – volume: 56 start-page: 559 year: 2013 end-page: 570 article-title: Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature publication-title: Mycoses – year: 2018 article-title: Siemens immulite Aspergillus‐specific IgG assay for chronic pulmonary aspergillosis diagnosis publication-title: Med Mycol – volume: 89 start-page: 864 year: 2011 end-page: 872 article-title: Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis publication-title: Bull World Health Organ – volume: 9 start-page: e114745 year: 2014 article-title: Estimation of the burden of chronic and allergic pulmonary aspergillosis in India publication-title: PLoS ONE – volume: 63 start-page: 433 year: 2016 end-page: 442 article-title: Executive summary: practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America publication-title: Clin Infect Dis – ident: e_1_2_5_15_1 doi: 10.1093/cid/ciw444 – ident: e_1_2_5_22_1 doi: 10.1111/myc.12541 – ident: e_1_2_5_7_1 doi: 10.1371/journal.pone.0114745 – ident: e_1_2_5_19_1 doi: 10.1111/j.1749-6632.1974.tb28200.x – ident: e_1_2_5_8_1 doi: 10.1016/j.diagmicrobio.2018.01.001 – ident: e_1_2_5_2_1 doi: 10.1016/j.cmi.2018.01.002 – ident: e_1_2_5_5_1 doi: 10.1086/376526 – ident: e_1_2_5_17_1 doi: 10.1016/j.jinf.2014.01.005 – ident: e_1_2_5_20_1 doi: 10.1016/j.alit.2018.04.009 – ident: e_1_2_5_6_1 doi: 10.2471/BLT.11.089441 – ident: e_1_2_5_9_1 doi: 10.1016/j.jinf.2015.11.003 – ident: e_1_2_5_14_1 doi: 10.1111/myc.12075 – ident: e_1_2_5_21_1 doi: 10.1093/mmy/myy012 – ident: e_1_2_5_11_1 doi: 10.1373/clinchem.2006.067546 – ident: e_1_2_5_3_1 doi: 10.1093/cid/ciw326 – ident: e_1_2_5_18_1 doi: 10.3109/13693786.2012.682228 – ident: e_1_2_5_10_1 doi: 10.1111/1469-0691.12133 – ident: e_1_2_5_16_1 doi: 10.1111/j.1440-1843.2009.01548.x – ident: e_1_2_5_4_1 doi: 10.1183/13993003.00583-2015 – ident: e_1_2_5_12_1 doi: 10.7150/ijbs.5459 – ident: e_1_2_5_13_1 doi: 10.1093/mmy/myy024 |
SSID | ssj0017926 |
Score | 2.4378495 |
Snippet | Aspergillus fumigatus‐specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis (CPA). However, the cut‐off value for... Aspergillus fumigatus ‐specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis ( CPA ). However, the cut‐off value for A. fumigatus... Aspergillus fumigatus-specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis (CPA). However, the cut-off value for... Aspergillus fumigatus‐specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis (CPA). However, the cut‐off value for A.... Aspergillus fumigatus-specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis (CPA). However, the cut-off value for A.... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 770 |
SubjectTerms | Adult Aged Alveoli Antibodies, Fungal - blood Aspergillosis Aspergillus Aspergillus fumigatus Aspergillus fumigatus - immunology Aspergillus fumigatus - isolation & purification Bronchus Chronic Disease chronic pulmonary aspergillosis Diagnosis ELISA Female Humans IgG ImmunoCap Immunoglobulin G Immunoglobulin G - blood Male Mannans - analysis Middle Aged Municipalities Precipitins Prospective Studies Pulmonary Aspergillosis - diagnosis Pulmonary Aspergillosis - diagnostic imaging Pulmonary Aspergillosis - microbiology Radiography, Thoracic ROC Curve Sensitivity and Specificity Sputum Tuberculosis Yard waste |
Title | Diagnostic cut‐off of Aspergillus fumigatus‐specific IgG in the diagnosis of chronic pulmonary aspergillosis |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fmyc.12815 https://www.ncbi.nlm.nih.gov/pubmed/29920796 https://www.proquest.com/docview/2111063305 https://www.proquest.com/docview/2057442793 |
Volume | 61 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwEB4hEBIX3o_yqAziwCVV0sRJI07l0WWRygGBBBJS5Dh2VVHSijQHOPET-I37S3YmTiLYXaQVt0geO449Y38Tj78BOHSEo7noOBaXXFmep11L4E5hha4MuKNtXxepE_pX_sWtd3nH72bguLoLY_gh6h9uZBnFek0GLuLsg5E_vcgWHQPRBXOK1SJAdF1TR6GeFanWyGG3AvRaSlYhiuKpa37ei_4CmJ_xarHh9JbgoeqqiTN5bOXTuCVf_2Bx_Oa3LMNiCURZ12jOCsyodBXmTWrKlzWYnJkYPCxlMp_-ensfa83GmnWJWnwwHI3yjOn8iRg68gyL6comhR2xn4MfbJgyBJYsMW0MM6ooDQ0vm-QjVH3sKxNVUySyDre985vTC6vMzmBJl7vcEgKRF3fjIHF8O7HDtq3iBPGL5BohYUeEQUxca3agdajoQq5NaRcdFSo_4aGv3A2YTcep2gKWBB2tHCHa6I97vo4RtAqEPopjE67sJA04quYpkiV1OWXQGEWVC4MDGBUD2ICDWnRi-Dr-JbRbTXZUmmwWoSeM7rGL618D9utiNDY6QRGpGucog-jW89q4pjVg0yhJ_Rbc19t2EPrY2WKqv3591L8_LR62_190BxYQqhkmXmcXZqfPudpDODSNmzDXPTk76TUL_f8NeRgIvA |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwEB7xEGIvy2MXKE-DOHBJlTRx0khcEK_yKAcEEhxWkePYVbUlrWhzYE_8BH4jv4SZOImABQlxi-TxI_aM_Y0f3wBsO8LRXDQdi0uuLM_TriVwpbBCVwbc0bav89AJ7Qu_de2d3vCbMdgt38IYfohqw40sI5-vycBpQ_qVld89yDqdA_FxmKSI3sScf3BZkUehpuXB1shltwL0WwpeIbrHU2V9uxr9BzHfItZ8yTmagT9lY81Nk7_1bBTX5b93PI7f_ZtZ-FlgUbZnlGcOxlQ6D1MmOuXDLxgcmGt4mMpkNnp-fOprzfqa7RG7eKfb62VDprM7IunIhphMrzbp5hE76RyzbsoQW7LElNEdUkZpmHjZIOuh9mNjmSiLIpHfcH10eLXfsooADZZ0ucstIRB8cTcOEse3Ezts2CpOEMJIrhEVNkUYxES3Zgdah4re5NoUedFRofITHvrKXYCJtJ-qJWBJ0NTKEaKBLrnn6xhxq0D0ozgW4cpmUoOdcqAiWbCXUxCNXlR6MdiBUd6BNdiqRAeGsuMjodVytKPCaocROsPoIbs4BdZgs0pGe6NDFJGqfoYyCHA9r4HTWg0WjZZUteDS3rCD0MfG5mP9efVR-3Y__1j-uugGTLeu2ufR-cnF2Qr8QORmiHmdVZgY3WdqDdHRKF7PjeAFm3ELZg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-VTkO88LEx6Chgpj3wkipfThrtqWopG9BqQkwaElLkOHZV0aYVbR66p_0J-xv3l3AXJ9E-QEK8RfLZcew7-3fx-XcAh45wNBddx-KSK8v3tWcJ3CmsyJMhd7Qd6CJ1wmgcHJ_5n875eQOOqrswhh-i_uFGllGs12Tgy1TfMPL5RnboGIg_gC0_sCPK2zD4WnNHoaIVudbIY7dCdFtKWiEK46mr3t6M7iHM24C12HGGT-BH1VcTaPKzk6-Tjry4Q-P4nx_zFB6XSJT1jOo8g4bKdmDb5Kbc7MJyYILwsJTJfH19ebXQmi006xG3-GQ6m-UrpvM5UXTkKyymO5sUd8ROJh_ZNGOILFlq2piuqKI0PLxsmc9Q97GvTFRNkchzOBt--NY_tsr0DJb0uMctIRB6cS8JUyewUztybZWkCGAk14gJuyIKEyJbs0OtI0U3cm3Ku-ioSAUpjwLl7UEzW2TqJbA07GrlCOGiQ-4HOkHUKhD7KI5NeLKbtuB9NU-xLLnLKYXGLK58GBzAuBjAFhzUoktD2PEnoXY12XFps6sYXWH0jz1cAFvwri5Ga6MjFJGpRY4yCG9938VFrQUvjJLUb8GN3bXDKMDOFlP999fHo-_94mH_30XfwsPTwTD-cjL-_AoeIWwzrLxOG5rrX7l6jdBonbwpTOA3egsKFQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diagnostic+cut-off+of+Aspergillus+fumigatus-specific+IgG+in+the+diagnosis+of+chronic+pulmonary+aspergillosis&rft.jtitle=Mycoses&rft.au=Sehgal%2C+Inderpaul+Singh&rft.au=Choudhary%2C+Hansraj&rft.au=Dhooria%2C+Sahajal&rft.au=Aggarwal%2C+Ashutosh+Nath&rft.date=2018-10-01&rft.eissn=1439-0507&rft.volume=61&rft.issue=10&rft.spage=770&rft_id=info:doi/10.1111%2Fmyc.12815&rft_id=info%3Apmid%2F29920796&rft.externalDocID=29920796 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0933-7407&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0933-7407&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0933-7407&client=summon |